Although osimertinib potently decreased DR4 levels including cell surface DR4 levels in sensitive EGFRm NSCLC cells, it still enhanced TRAIL-induced apoptosis in these cell lines as we recently reported 41. Here, TNFRSF10A is linked to non-small cell lung carcinoma.